Machine learning models can predict postoperative hyperopic shift in patients with primary angle-closure glaucoma.

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

Sperone Westwater Gallery to close after 50 years. The gallery has been telling contractors it's not continuing after ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Trial at 36 Months: 37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose groups with 95% of patients off all topical IOP-lowering drops100% of evaluable patients ...

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

Glaucoma is an incurable and relatively common eye disease that can lead to blindness. In our research group, we investigate how the disease progresses and explore potential therapies. The group ...

Monitoring IOP fluctuations and initial VFI slope in angle closure can help tailor treatment strategies. Greater intraocular pressure (IOP) fluctuations and early declines in visual field index (VFI) ...

IF you’ve got kids or grandchildren, you should know about meningitis. Cases of the potentially fatal condition, which causes ...

Men and patients with particular clinical characteristics are more likely to present with angle closure glaucoma of greater severity. Severe visual field (VF) loss is more common at the first ...